Fri. Sep 30th, 2022

A cancer treatment based upon the innovation behind Oxford Universitys Covid-19 jab will be evaluated on humans for the very first time after strong lead to animal experiments.The “cancer vaccine” was able to shrink tumours in mice. It also improved their survival rates when it was combined with another type of treatment that is designed to turn an individuals body immune system versus their cancer.The results have actually led the way for the very first human trial, which will include 80 clients with a form of the illness called non-small cell lung cancer. The Oxford group said that the underlying innovation could “change” treatment for a series of cancers.It is the very same “viral vector” innovation that lies at the heart of the Oxford-AstraZeneca Covid-19 jab.

By

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Wizadclick | WAC MAG 2022